Astrotech Corporation (NASDAQ:ASTC – Get Free Report) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totaling 38,911 shares, a decline of 95.9% from the March 31st total of 960,143 shares. Based on an average daily trading volume, of 594,830 shares, the days-to-cover ratio is currently 0.1 days. Currently, 2.7% of the shares of the stock are sold short.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Astrotech in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.
Check Out Our Latest Research Report on ASTC
Astrotech Trading Up 4.6%
Astrotech (NASDAQ:ASTC – Get Free Report) last posted its quarterly earnings data on Friday, February 13th. The aerospace company reported ($2.34) earnings per share (EPS) for the quarter. Astrotech had a negative return on equity of 68.53% and a negative net margin of 1,163.89%.The firm had revenue of $0.15 million during the quarter.
Hedge Funds Weigh In On Astrotech
An institutional investor recently raised its position in Astrotech stock. DRW Securities LLC increased its stake in Astrotech Corporation (NASDAQ:ASTC – Free Report) by 168.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,464 shares of the aerospace company’s stock after acquiring an additional 19,747 shares during the period. DRW Securities LLC owned about 1.79% of Astrotech worth $109,000 as of its most recent SEC filing. 24.35% of the stock is currently owned by institutional investors and hedge funds.
Astrotech Company Profile
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
See Also
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
